The medtech blueprint: Accelerating South Florida’s healthcare economy

Writer: Dr. Dylan Attard, Founder and CEO, MedTech World

Key points:

  • • South Florida has strong healthcare assets, but its growth depends on better connecting research, capital, and hospitals.
  • • The region must streamline clinical access, align specialized capital, and develop local talent to retain emerging companies.
  • • MedTech World selected West Palm Beach to bridge local startups with international networks and foster long-term expansion.

South Florida's healthcareNovember 2026 — South Florida has many of the ingredients of a strong healthcare innovation economy. The question is how effectively the region can connect them so that more companies develop here, grow here, and bring useful technologies into patient care. That is the opportunity I see, and the reason we chose West Palm Beach as the U.S. home for MedTech World.


Join us at caa’s upcoming leadership summits! These premier events bring together hundreds of public and private sector leaders to discuss the challenges and opportunities for businesses and investors. Find the next summit in a city near you!


As a doctor, I judge healthcare innovation by what it can change for patients and the people treating them. As someone working with founders and investors internationally, I also see the business conditions that determine whether a promising technology gets that far. A region can have excellent research, substantial wealth, and busy hospitals while the route between them remains difficult for an emerging company to navigate.

South Florida has an opportunity to make that route clearer. Doing so would give it a stronger proposition for attracting international companies and retaining the businesses its own institutions help create.

A regional opportunity

The research foundations are tangible. The Wertheim UF Scripps Institute in Jupiter provides an established base in biomedical discovery. Florida Atlantic University achieved R1 research designation in 2025. Alongside these institutions, the wider South Florida region brings healthcare providers, entrepreneurs, and financial networks. These assets serve different purposes, but their connections are what can make the region more valuable to a growing company.

That regional perspective matters. A founder considering West Palm Beach is also assessing the clinical partners, expertise, and investors available across Palm Beach County and beyond. Economic development efforts should make those relationships easier to access, even when they cross city and county boundaries.

This is part of what attracted us. MedTech World began in Malta and has grown into a platform connecting healthcare founders, clinicians, investors, and industry across international markets. We chose West Palm Beach because we see scope for a lasting exchange: helping local companies reach partners overseas while bringing international businesses into the region. For that exchange to produce lasting economic value, three priorities deserve attention.


Read more from Dr. Dylan Attard here.


Make clinical collaboration easier to navigate

For an emerging healthcare company, access to a clinician is only the beginning. The company needs to understand who can assess its technology, what evidence is required, how an evaluation would be approved, and whether there is a realistic route to adoption. A successful pilot does not automatically lead to a purchasing decision.

Hospitals have legitimate demands around safety, staff capacity, and cost. A useful regional approach would help founders understand those demands earlier, with clearer points of contact and expectations for evaluation. It would also help clinicians identify technologies addressing problems they actually need solved.

In my view, the ability to navigate that process should be part of South Florida’s offer to companies considering a presence here. Clinical access becomes a stronger economic asset when businesses can understand how to engage with it.

Connect capital with healthcare expertise

The presence of wealth creates an opening, but healthcare companies need investors who understand the particular business they are backing. A surgical device, a diagnostic test, and a digital health platform have different evidence requirements, customers, and routes to revenue. Treating them as a single investment category can obscure the risks and the opportunities.

South Florida can strengthen its proposition by deepening relationships between local capital and specialist healthcare investors. Co-investment and access to experienced clinical and commercial advisors could help investors assess opportunities while giving founders more informed support. Success should be measured partly by whether companies can secure the funding needed for their next meaningful milestone and continue developing in the region.

Build the expertise that helps companies stay

Research can produce a company’s first idea. Building that company requires people who know how to develop evidence, manage quality, work through regulatory requirements, and sell into healthcare. Access to that experience influences where founders choose to build their teams.

University commercialization efforts, employers, and economic development organizations have a shared interest here. Connecting emerging businesses with experienced operators, and creating opportunities for local graduates to work alongside them, would help build expertise that remains in the region. Attracting companies matters; giving them reasons to expand locally matters just as much.

Measure what continues after the introduction

This also sets a standard for organizations like ours. Bringing people together is useful when it leads to work that continues afterward. Our contribution should be judged by the partnerships we help initiate and sustain, and by whether our international network gives local companies access they would otherwise struggle to secure.

We intend to keep building those connections through MedTech World’s presence in West Palm Beach. The wider ambition is a region where a founder can find a clinical collaborator, an investor can access relevant expertise, and a growing company can assemble the team it needs to stay.

South Florida’s healthcare innovation story will be shaped by how reliably those things happen. That is where I believe the next phase of growth should focus.

Want more? Read the Invest: reports.


Make caa your preferred source on Google and stay locked in to the business insights shaping U.S. markets.